These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Mason DT Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030 [TBL] [Abstract][Full Text] [Related]
4. Afterload reduction in the treatment of cardiac failure. Mason DT Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. Franciosa JA; Cohn JN Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986 [TBL] [Abstract][Full Text] [Related]
6. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
8. Vasodilators in left ventricular failure. Camerini F; Mestroni L; Neri R; Humar F G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364 [TBL] [Abstract][Full Text] [Related]
10. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031 [TBL] [Abstract][Full Text] [Related]
11. New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure. Packer M Am J Med; 1983 Jun; 74(6B):61-72. PubMed ID: 6859073 [TBL] [Abstract][Full Text] [Related]
12. [Vasodilator therapy in cardiac failure]. Akatsuka N Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237 [TBL] [Abstract][Full Text] [Related]
15. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. Chatterjee K; Parmley WW J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075 [TBL] [Abstract][Full Text] [Related]
16. Role of vasodilators in the treatment of congestive heart failure. Levine TB Am J Cardiol; 1985 Jan; 55(2):32A-35A. PubMed ID: 2981463 [TBL] [Abstract][Full Text] [Related]
18. The role of vasodilator therapy in the treatment of severe chronic heart failure. Packer M Drugs; 1986; 32 Suppl 5():13-26. PubMed ID: 3552590 [TBL] [Abstract][Full Text] [Related]
19. Preload and afterload without anguish: a simplified framework. Mandell HN; Deglin SM Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231 [No Abstract] [Full Text] [Related]
20. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)]. Solignac A Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]